Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02819973
Other study ID # Pro00071154
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 2016
Est. completion date April 30, 2020

Study information

Verified date March 2021
Source Duke University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

VIVID is a prospective, multicenter, randomized clinical trial in African American patients that will to evaluate: (1) the effect of an educational video on knowledge of sudden cardiac death (SCD) and implantable cardioverter defibrillators (ICDs); (2) the effect of an educational video on the decision for ICD implantation, decisional conflict, and receipt of an ICD within 90 days; and 3) the effect of racial concordance between study patients and video participants (health care providers/patients) on the decision for ICD implantation, decisional conflict and ICD receipt within 90 days.


Description:

VIVID is a prospective, multicenter, randomized clinical trial that will evaluate three specific research questions. In black patients eligible for a primary prevention implantable cardioverter defibrillator (ICD), 1) what is the effect of a patient-centered educational video compared with usual care (UC) on knowledge of SCD (Sudden Cardiac Death), associated risk factors, and ICDs; 2) what is the effect of a patient-centered educational video compared with UC on the decision for ICD implantation, decisional conflict, and receipt of an ICD within 90 days; 3) what is the effect of racial concordance between study patients and video participants (health care providers/patients) on the decision for ICD implantation, decisional conflict and ICD receipt within 90 days. In addition, in-depth qualitative interviews (IQI) with a sample of trial participants will be conducted to determine the salient influences on their decision and explore the reasons for their ultimate decision and subsequent implantation or non-implantation of an ICD. Approximately 480 patients eligible for a primary prevention ICD will be enrolled at approximately 12 hospitals in this study. Study sites selected for VIVID will be geographically diverse and provide care to a significant proportion of racial and ethnic minority patients. Patient's will be mailed a letter regarding the study, prior to their initial visit. At the initial visit, patients will be approached about participation in the trial. For those interested, informed consent will be obtained and patients will be randomized. The investigators will be utilizing electronic consents on an iPad. Black patients will be randomized to one of 3 arms: educational videos presented in the same format; one with black participants (patients and providers) or the other with white participants (patients and providers); The third arm will be usual care (control) and the provider can interact with the patient consistent with their typical/usual care. Notably, for both intervention and control arms, all patient management decisions are completely at the discretion of the care providers.


Recruitment information / eligibility

Status Completed
Enrollment 343
Est. completion date April 30, 2020
Est. primary completion date January 28, 2020
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: 1. Non-hospitalized patients with ejection fraction =35% 2. New York Heart Association class I-III heart failure, 3. Age >21 4. Eligible for an implantable cardioverter defibrillator (ICD) for the primary prevention of sudden cardiac death 5. Self-identified race as black 6. Provision of informed consent to participate in the study. Exclusion Criteria: 1. Life expectancy <12 months 2. Listed for Orthotropic Heart Transplantation (OHT) 3. Transplant (OHT) or OHT imminent within 12 months, 4. History of ventricular fibrillation or sustained ventricular tachycardia without reversible causes 5. ICD already implanted 6. Myocardial infarction within the last 40 days, 7. Coronary revascularization within the last 3 months, 8. Patients who are unable to understand the study procedures due to cognitive or language barriers. 9. Inpatients will be excluded from the study because decision-making processes are thought to be appreciably different in inpatients as compared with outpatients. 10. Plan for subcutaneous ICD (Sub-Q ICD)

Study Design


Intervention

Other:
Educational Video1

Educational Video 2

Usual Care 3


Locations

Country Name City State
United States Emory University School of Medicine Atlanta Georgia
United States Medstar Health Research Institute Baltimore Maryland
United States Montefiore Medical Center Bronx New York
United States Cooper University Hospital Camden New Jersey
United States South Carolina Heart Columbia South Carolina
United States Henry Ford Hospital Detroit Michigan
United States Duke University Medical Center Durham North Carolina
United States Jackson Heart Jackson Mississippi
United States Georgia Arrhythmia Consultants and Research Institute Macon Georgia
United States Vanderbilt University Medical Center Nashville Tennessee
United States Rutgers Robert Wood Johnson Medical School New Brunswick New Jersey
United States Drexel University College of Medicine Philadelphia Pennsylvania
United States University of California at San Francisco San Francisco California
United States Medstar Washington Hospital Center Washington District of Columbia

Sponsors (2)

Lead Sponsor Collaborator
Duke University Patient-Centered Outcomes Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other In-depth Interview Focused on Barriers to ICD Placement Following the Initial Decision In-depth phone interview 3 Month
Other In-depth Qualitative Interviews Focused on Impact of the Video on the Decision In-depth phone interview 3 Month
Other In-depth Interview Focused on Barriers to ICD Placement Following the Initial Decision In-depth phone interview 1 week
Other In-depth Qualitative Interviews Focused on Influences on the Decision to Accept or Decline an ICD In-depth phone interview 3 Month
Other In-depth Qualitative Interviews Focused on Impact of the Video on the Decision In-depth phone interview 1 week
Other In-depth Qualitative Interviews Focused on Knowledge of SCD and ICD In-depth phone interview 3 Month
Other In-depth Qualitative Interviews Focused on Influences on the Decision to Accept or Decline an ICD In-depth phone interview 1 week
Other In-depth Qualitative Interviews Focused on Knowledge of SCD and ICD Therapy In-depth phone interview 1 week
Primary Proportion of Patients Saying "Yes" to ICD Proportion of patients who have decided by 7 days to receive an ICD among patients randomized to the video intervention compared with health care provider counseling (usual care) 7 days
Secondary Proportion of Individuals Saying Yes to ICD Implant in the Racially Concordant Video Proportion of patients who watched a racially concordant video and who decided by 7 days to receive an ICD 7 days
Secondary Changes in Patient Knowledge (Pre and Post Intervention) Difference in Knowledge Questionnaire scores before and after receiving the intervention. Range of 0 to 13, with higher score indicating greater knowledge about ICDs. Baseline preintervention and Baseline (approximately 20mins later) post intervention
Secondary Changes in Decisional Conflict (Pre and Post) Difference in Decisional Conflict Scale score from baseline pre-intervention to 1 week post-intervention, range of 0-100 with higher value indicating greater conflict about the decision to receive an ICD. Baseline pre intervention and 1 week post intervention
Secondary ICD Receipt Within 90 Days of Enrollment. Number of participants receiving ICD implant within 90 days of enrollment as assessed by medical record review. 3 Months
Secondary Time Spent With Patients by Providers in Each Arm of the Study Number of minutes spent with patients during baseline visit as measured by baseline questionnaire timer Baseline
Secondary Patient Knowledge Assessment of knowledge retention at one week through re-administration of baseline Knowledge Questionnaire. Scale of 0-13, with higher score indicating more knowledge about ICDs. 1 week
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy